Breaking News, Financial News

Financial Report: PAREXEL 1Q11

Clinical Research Services (CRS) revenue was $231.6 million in the quarter (+14%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL 1Q11

1Q Revenues: $342.3 million (+11%)

1Q Earnings:
$17.8 million (+44%)

Comments:
Clinical Research Services (CRS) revenue was $231.6 million in the quarter (+14%). PAREXEL Consulting & Medical Communications Services (PCMS) accounted for $28.3 million (-2%). Perceptive Informatics, Inc. (PII) Service revenue was $35.8 million (+25%). The Americas accounted for $132.9 million (+31%), Europe, Middle East & Africa, $125.5 million (-3%), and Asia/Pacific, $37.4 million (+31%).

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters